Related Experiment Video
Updated: May 23, 2025
07:28
Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
Published on: October 29, 2020
8.6K
Ciprofloxacin-Induced Leukocytoclastic Vasculitis
André Cabrita1, Pedro Lisboa Gonçalves2, Catarina A Marques1
1Cardiology Department, Unidade Local De Saúde São João, Porto, PRT.
Cureus
|March 10, 2025
Summary
Ciprofloxacin, a common antibiotic, can rarely cause leukocytoclastic vasculitis (LCV). This case report highlights a patient who recovered quickly after stopping the drug, demonstrating a rare adverse reaction.
Area of Science:
- Pharmacology
- Dermatology
- Nephrology
Background:
- Ciprofloxacin is a frequently prescribed fluoroquinolone antibiotic used for empiric treatment of various infections.
- Adverse drug reactions associated with ciprofloxacin can range from mild to severe, necessitating careful monitoring.
- Leukocytoclastic vasculitis (LCV) is a potential, albeit rare, adverse effect of ciprofloxacin therapy.
Keywords:
adverse drug reactionsciprofloxacindrug-induced vasculitisfluoroquinolonesleukocytoclastic vasculitisMore Related Videos
Related Concept Videos
01:27Disorders of Leukocytes
825
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
825
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107